SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (2479)8/18/2018 7:43:26 PM
From: Felix B  Read Replies (2) | Respond to of 3559
 
I am not as worried about the threat to Eylea, similar to Humira they will have established a brand and unless the NVS drug is that much more potent (they are just non-inferior correct in H2H?), I think Eylea will stand up to competition.